Literature DB >> 1697126

The respiratory syncytial virus subgroup B attachment glycoprotein: analysis of sequence, expression from a recombinant vector, and evaluation as an immunogen against homologous and heterologous subgroup virus challenge.

W M Sullender1, K Anderson, G W Wertz.   

Abstract

The attachment glycoprotein G of respiratory syncytial (RS) virus is important in both the antigenic and molecular diversity of the RS viruses. Previous work has shown that the glycoprotein G of a subgroup A RS virus expressed from a recombinant vaccinia virus provides significant protection against homologous but not heterologous subgroup virus challenge. We undertook the cDNA cloning and nucleotide sequencing of the G mRNA of a subgroup B RS virus (8/60) to extend molecular comparisons of the G protein both within and between subgroups. We also tested the ability of a subgroup B G protein to provide protection against challenge by A or B subgroup viruses. Sequence analysis showed a deduced amino acid sequence having a single major open reading frame encoding a protein of 292 amino acids with an elevated serine and threonine (30%) and proline (9%) content. The 8/60 G differed from a subgroup A virus (A2) G protein with only a 56% amino acid identity while the 8/60 G shared a 98% amino acid identity with the G protein of another subgroup B virus (18537). The 8/60 G cDNA was placed in a vaccinia virus vector (vvGB) which was shown to express the 8/60 G protein. Cotton rats immunized intradermally with vvGB and later challenged intranasally with 8/60 RS virus had a significant reduction in viral titers in the lungs relative to control animals whereas similarly immunized animals were not protected against heterologous subgroup challenge. Our results indicate that a RS virus subunit vaccine containing the G protein would require both A and B subgroup G proteins to afford protection against viruses of both subgroups.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1697126     DOI: 10.1016/0042-6822(90)90394-7

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  20 in total

1.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

2.  Premature stop codons in the G glycoprotein of human respiratory syncytial viruses resistant to neutralization by monoclonal antibodies.

Authors:  P Rueda; T Delgado; A Portela; J A Melero; B García-Barreno
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

3.  Genetic and antigenic variability of human respiratory syncytial virus (groups a and b) isolated over seven consecutive seasons in Argentina (1995 to 2001).

Authors:  Monica C Galiano; Concepcion Palomo; Cristina M Videla; Juan Arbiza; José A Melero; Guadalupe Carballal
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

4.  Genetic variability among group A and group B respiratory syncytial viruses in a children's hospital.

Authors:  W B Coggins; E J Lefkowitz; W M Sullender
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

Review 5.  Respiratory syncytial virus genetic and antigenic diversity.

Authors:  W M Sullender
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

6.  Determination of the disulfide bond arrangement of human respiratory syncytial virus attachment (G) protein by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  J J Gorman; B L Ferguson; D Speelman; J Mills
Journal:  Protein Sci       Date:  1997-06       Impact factor: 6.725

7.  Inhibition of Na+ transport in lung epithelial cells by respiratory syncytial virus infection.

Authors:  Lan Chen; Weifeng Song; Ian C Davis; Kedar Shrestha; Erik Schwiebert; Wayne M Sullender; Sadis Matalon
Journal:  Am J Respir Cell Mol Biol       Date:  2008-10-23       Impact factor: 6.914

8.  Analysis of respiratory syncytial virus genetic variability with amplified cDNAs.

Authors:  W M Sullender; L Sun; L J Anderson
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

Review 9.  Understanding the mechanisms of viral induced asthma: new therapeutic directions.

Authors:  Nicole G Hansbro; Jay C Horvat; Peter A Wark; Philip M Hansbro
Journal:  Pharmacol Ther       Date:  2008-01-29       Impact factor: 12.310

10.  Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infection.

Authors:  Jae-Rang Yu; Sol Kim; Jee-Boong Lee; Jun Chang
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.